Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KDventures ABKDEVF 26 3-Year EPS without NRI Growth Rate is 22.60% as of Mar. 2026, which is 31% above its 10-year median of 17.20. GuruFocus rates KDEVF with a GF Score™ of 26/100 and a GF Value™ of $0.68. The stock has 3 warning signs investors should review. Among 1,167 Biotechnology companies, KDventures AB ranks better than 57.58% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 22.60% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 17.50% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 30.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of KDventures AB was 52.60% per year. The lowest was -191.50% per year. And the median was 17.20% per year.
KDventures AB (OTCPK:KDEVF) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
KDventures AB 3-Year EPS without NRI Growth Rate Related Terms
KDEVF vs VRTX, REGN, ALNY: 3-Year EPS without NRI Growth Rate Comparison
For the Biotechnology subindustry, KDventures AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB 3-Year EPS without NRI Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where KDventures AB's 3-Year EPS without NRI Growth Rate falls into.
KDventures AB 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 22.60% mean?
KDventures AB (KDEVF) has a 3-Year EPS without NRI Growth Rate of 22.60% as of Mar. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for KDventures AB and its competitors. This is 31% above median its historical median of 17.20. According to the industry distribution chart, KDventures AB ranks #495 out of 1167 companies in the Biotechnology industry, placing it in the top 42.4%.
Is KDventures AB's 3-Year EPS without NRI Growth Rate too high?
KDventures AB's current 3-Year EPS without NRI Growth Rate of 22.60% is 31% above median its 10-year median of 17.20. The Biotechnology industry median 3-Year EPS without NRI Growth Rate is 16.60. KDventures AB's value of 22.60% is 36.1% above this industry median. Based on the distribution chart, KDventures AB ranks #495 out of 1167 companies in the Biotechnology industry, which is above the industry midpoint. Overall, KDventures AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's 3-Year EPS without NRI Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #495 out of 1167 companies for 3-Year EPS without NRI Growth Rate. This puts KDventures AB in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 16.60. KDventures AB's value of 22.60% is 36.1% above this benchmark. While the company's 10-year median is 17.20 vs. the industry median of 16.60, KDventures AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Biotechnology company?
The median 3-Year EPS without NRI Growth Rate among Biotechnology companies is 16.60, based on 1,167 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDventures AB's current 3-Year EPS without NRI Growth Rate of 22.60% is 36.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for KDventures AB and its competitors. For the Biotechnology industry, the median 3-Year EPS without NRI Growth Rate is 16.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current 3-Year EPS without NRI Growth Rate is 22.60%, which is 31% above median its own 10-year median of 17.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current 3-Year EPS without NRI Growth Rate of 22.60%. The stock's GF Value™ is $0.68, compared to a current price of $0.26 — trading 62.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 22.60%, which is 31% above median its 10-year median of 17.20 and 36.1% above the Biotechnology industry median of 16.60. KDventures AB's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For KDventures AB (KDEVF), the current 3-Year EPS without NRI Growth Rate is 22.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 62.1% below its estimated GF Value™ of $0.68.
Key valuation signals for KDEVF:
3-Year EPS without NRI Growth Rate: 22.60% (31% above median its 10-year median of 17.20)
GF Value™: $0.68 vs. price of $0.26 (62.1% below fair value)
Industry Position: 36.1% above the Biotechnology median (#495 of 1167)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
26GF Score
Get the complete analysis for KDEVF
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
